Vergleich

Bcl-x

ArtNr 20-203-420007
Hersteller GENWAY
Menge 0,1 ml
Kategorie
Typ Antibody
Applikationen WB, FC, IP, IHC, ICC
Specific against other
ECLASS 5.1 32160702
ECLASS 6.1 32160702
ECLASS 8.0 32160702
ECLASS 9.0 32160702
ECLASS 10.0.1 32160702
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-8BE3E3
Similar products 20-203-420007
Lieferbar
Genway ID:
GWB-8BE3E3
Clone ID:
E18
Immunogen:
A synthetic peptide corresponding to residues between BH3 and BH3 of Human Bcl-x was used as the immunogen. This antibody should recognize Bcl-xL Bcl-xS and Bcl-x(beta) as the immunogen sequence is common to them. The antibody does not cross-react with o
Specificity:
A synthetic peptide corresponding to residues between BH3 and BH3 of Human Bcl-x was used as the immunogen. This antibody should recognize Bcl-xL Bcl-xS and Bcl-x(beta) as the immunogen sequence is common to them. The antibody does not cross-react with other Bcl-2 family members.
Dilution:
WB: 1:500 - 1000IHC: 1:50 - 1:100ICC: 1:100FC: 1:50IP: 1:10. Bcl-x a member of the Bcl-2 protein family inhibits cell death or apoptosis (1). Bcl-x is expressed as two isomeric forms Bcl-xL and Bcl-xS and is typically present in the cytosol in association with the mitochondrial membrane. Bcl-xL forms heterodimers with various proteins including Bax Bak and Bcl-2(2). It has been found that eterodimerization with Bax does not seem to be required for anti-apoptic activity (3). Since Bcl-xL can form an ion channel in synthetic lipid membranes there is a strong possibility that this property plays a role in heterodimerization-independent cell survival (4). The Bcl-X(S) isoform promotes apoptosis. 1. Kornasio R Riederer I Butler-Browne G et al Î ² -hydroxy-Î ² -methylbutyrate (HMB) stimulates myogenic cell proliferation differentiation and survival via the MAPK/ERK and PI3K/Akt pathways Biochim Biophys Acta. 1793 (2009) 755-763[Application: ICC]2. Ge F Lu XP Zeng HL et al Proteomic and Functional Analyses Reveal a Dual Molecular Mechanism Underlying Arsenic-Induced Apoptosis in Human Multiple Myeloma Cells J. Proteome Res. 8 (2009) 3006-3019[Application: WB]3. Xie W Song CY Young NL et al Histone H3 Lysine 56 Acetylation Is Linked to the Core Transcriptional Network in Human Embryonic Stem Cells Molecular Cell 33 (2009) 417-427[Application: WB]4. Scholl FA Dumesic PA Barragan DI et al Mek1/2 MAPK Kinases Are Essential for Mammalian Development Homeostasis and Raf-Induced Hyperplasia Developmental Cell 12 (2007) 615-629[Application: IHC]5. Kaushansky N Altmann DM Ascough S et al HLA-DQB1*0602 Determines Disease Susceptibility in a New Humanized Multiple Sclerosis Model in HLA-DR15 (DRB1*1501; DQB1*0602) Transgenic Mice J. Immunol. 183 (2009) 3531 - 3541[Application: ]6. Tan KB Lee YS Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology Histopathology 55 (2009) 338-345[Application: IHC]7. Kornasio R Riederer I Butler-Browne G et al Î ² -hydroxy-Î ² -methylbutyrate (HMB) stimulates myogenic cell proliferation differentiation and survival via the MAPK/ERK and PI3K/Akt pathways Biochim Biophys Acta. 1793 (2009) 755-763[Application: ICC]8. Gallenne T Gautier F Oliver L et al Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members J. Cell Biol. 185 (2009) 279 - 290[Application: IP]9. Ge F Lu XP Zeng HL et al Proteomic and Functional Analyses Reveal a Dual Molecular Mechanism Underlying Arsenic-Induced Apoptosis in Human Multiple Myeloma Cells J. Proteome Res. 8 (2009) 3006-3019[Application: WB]10. Gallenne T Gautier F Oliver L et al Bcl-x J Cell Biol 185 (2009) 279-290[Application: IP]11. Priault M Hue E Marhuenda F et al Differential Dependence on Beclin 1 for the Regulation of Pro-Survival Autophagy by Bcl-2 and Bcl-xL in HCT116 Colorectal Cancer Cells PLoS One 5 (2010) e8755[Application: IP]1. Boise L. H. et al. Cell 74(4): 597-608 (1993)2. Sedlak T. W. et al. PNAS U S A. 92(17): 7834-8 (1995)3. Cheng E. H. et al. Nature 379(6565): 554-6 (1996)4. Minn A. J. et al. EMBO. J. 18: 632-643 (1999)5. Manufactured under U. S. Patents No. 5 675 063 and 7 429 487

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 0,1 ml
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen